534 related articles for article (PubMed ID: 27520093)
1. Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.
Khan F; Huang H; Datta YH
J Thromb Thrombolysis; 2016 Nov; 42(4):573-8. PubMed ID: 27520093
[TBL] [Abstract][Full Text] [Related]
2. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
3. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation.
Becattini C; Giustozzi M; Ranalli MG; Bogliari G; Cianella F; Verso M; Agnelli G; Vedovati MC
J Thromb Haemost; 2018 May; 16(5):833-841. PubMed ID: 29460334
[TBL] [Abstract][Full Text] [Related]
4. Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
Noseworthy PA; Yao X; Gersh BJ; Hargraves I; Shah ND; Montori VM
Int J Cardiol; 2017 Oct; 245():174-177. PubMed ID: 28733071
[TBL] [Abstract][Full Text] [Related]
5. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
[No Abstract] [Full Text] [Related]
7. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
8. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
9. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation.
Xu Y; Chang AR; Inker LA; McAdams-DeMarco M; Grams ME; Shin JI
J Am Heart Assoc; 2022 Jul; 11(14):e025723. PubMed ID: 35861836
[TBL] [Abstract][Full Text] [Related]
11. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
12. Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study).
Turagam MK; Parikh V; Afzal MR; Gopinathannair R; Lavu M; Kanmanthareddy A; Pillarisetti J; Reddy M; Atkins D; Bommana S; Jaeger M; Jeffery C; Mohanty S; Santangeli P; Cheng J; Di Biase L; Narasimhan C; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2017 Aug; 28(8):853-861. PubMed ID: 28497899
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin-naïve or warfarin-experienced patients.
Perino AC; Fan J; Pundi K; Schmitt S; Kothari M; Din N; Heidenreich PA; Turakhia MP
Clin Cardiol; 2022 Sep; 45(9):960-969. PubMed ID: 35946047
[TBL] [Abstract][Full Text] [Related]
14. Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States.
Lip GY; Pan X; Kamble S; Kawabata H; Mardekian J; Masseria C; Bruno A; Phatak H
Int J Clin Pract; 2016 Sep; 70(9):752-63. PubMed ID: 27550177
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study.
Poli D; Antonucci E; Ageno W; Bertù L; Migliaccio L; Martinese L; Pilato G; Testa S; Palareti G
PLoS One; 2019; 14(5):e0216831. PubMed ID: 31120890
[TBL] [Abstract][Full Text] [Related]
16. Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system.
Grant SJ; Kothari S; Gimotty PA; Gooneratne NS; Cuker A
J Thromb Thrombolysis; 2018 Jul; 46(1):1-6. PubMed ID: 29611105
[TBL] [Abstract][Full Text] [Related]
17. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
18. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
19. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
Lee SI; Sayers M; Lip GY; Lane DA
Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
